Latest Articles
Yes, AI can predict your embryo's risk of cancer - Axios
Yes, AI can predict your embryo's risk of cancer Axios
Published: Oct. 21, 2025, 10:25 p.m.
Adiposity, Metabolites Linked to Endometrial Cancer - bioengineer.org
Adiposity, Metabolites Linked to Endometrial Cancer bioengineer.org
Published: Oct. 21, 2025, 2:27 p.m.
Adiposity, Metabolites Linked to Endometrial Cancer - Bioengineer.org
Adiposity, Metabolites Linked to Endometrial Cancer Bioengineer.org
Published: Oct. 21, 2025, 2:27 p.m.
Adiposity, Metabolites Linked to Endometrial Cancer - BIOENGINEER.ORG
Adiposity, Metabolites Linked to Endometrial Cancer BIOENGINEER.ORG
Published: Oct. 21, 2025, 2:27 p.m.
Comparison of identification of sentinel lymph nodes between ICG vs methylene blue in v notes staging surgery for endometrial cancer - BMC Surgery
Comparison of identification of sentinel lymph nodes between ICG vs methylene blue in v notes staging surgery for endometrial cancer BMC Surgery
Published: Oct. 21, 2025, 11:10 a.m.
Obesity-related cancers rising across all age groups - Female First
Obesity-related cancers rising across all age groups Female First
Published: Oct. 21, 2025, 10:30 a.m.
Dana-Farber Research Uncovers Potential Targeted Therapy for Endometrial Cancer - Dana-Farber Cancer Institute
Dana-Farber Research Uncovers Potential Targeted Therapy for Endometrial Cancer Dana-Farber Cancer Institute
Published: Oct. 21, 2025, 9 a.m.
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - BioSpace
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer BioSpace
Published: Oct. 21, 2025, 5:15 a.m.
KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer - Pharmacy Times
KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer Pharmacy Times
Published: Oct. 21, 2025, 3:34 a.m.
Investors Show Faith In Faeth’s Cancer Metabolism Strategy As Data Read Out At ESMO - Citeline News & Insights
Investors Show Faith In Faeth’s Cancer Metabolism Strategy As Data Read Out At ESMO Citeline News & Insights
Published: Oct. 20, 2025, 10:35 p.m.
Link copied to clipboard!